GET DAILY SIGNALSGrindr (GRND) Q3 Revenue Climbs 22% as Guidance Gets a Boost
Key Takeaways
- Grindr reported third-quarter 2026 revenue of $141.4 million, up 22% year over year and above the consensus estimate of roughly $135.8 million.
- Adjusted EBITDA rose to $61.7 million, a 43.7% margin, compared with $54.8 million a year earlier.
- The company posted a net loss of $6.6 million, driven largely by transaction-related costs tied to its acquisition of PurposeMed (Freddie) and a non-cash derivative fair-value charge.
- Management raised its full-year 2026 outlook to revenue of at least $560 million and Adjusted EBITDA of at least $236 million.
- Grindr also introduced initial 2027 guidance calling for revenue of at least $705 million and Adjusted EBITDA of at least $275 million.
Why This Quarter Matters
Grindr’s third-quarter report provides a useful check on whether the company can maintain its rapid, high-margin expansion while integrating its largest recent strategic move. The period ended just before the November 2, 2026 close of the PurposeMed (Freddie) acquisition, which brings healthcare services into Grindr’s core social-networking and subscription operations. I was particularly interested in signs of continued monetization strength, paying-user trends, and any early indications around the Edge AI premium tier. Given Grindr’s combination of double-digit revenue growth and strong cash generation, these releases also offer insight into operating leverage and the balance between reinvestment and returns.
The Quarter in Numbers
For the three months ended September 30, 2026, GRND posted revenue of $141.4 million, a 22% increase from $115.8 million in the prior-year quarter and ahead of the roughly $135.8 million consensus estimate. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Adjusted EBITDA reached $61.7 million, up from $54.8 million a year earlier, for a margin of 43.7%. The company recorded a net loss of $6.6 million versus net income of $30.8 million in the same period last year. Management attributed the swing mainly to transaction costs from the Freddie deal and a non-cash charge related to the fair-value change of a derivative embedded in forward repurchase transactions.
Alongside the results, guidance for full-year 2026 was raised to revenue of at least $560 million and Adjusted EBITDA of at least $236 million. Initial 2027 targets call for revenue of at least $705 million and Adjusted EBITDA of at least $275 million.
Market Reaction and Sentiment
Investor attention focused on the contrast between a solid top-line beat and raised outlook on one side, and the headline net loss plus acquisition-integration costs on the other. Most looked past the quarterly loss, viewing it as driven by identifiable, largely non-recurring items rather than any deterioration in core operations. The updated 2026 targets and new 2027 framework added helpful forward visibility. That said, some caution remains around the added operational complexity from the Freddie acquisition and the expectation that advertising growth will moderate next year.
Key Items to Follow
Going forward, attention will center on execution against the new guidance, with the Freddie acquisition expected to contribute only modestly in the fourth quarter. The 2027 outlook implies roughly 26% revenue growth and margins of about 39% or better. The Edge AI premium tier remains a longer-term opportunity not yet fully reflected in near-term forecasts. Integration progress on clinical and pharmacy infrastructure, along with whether Freddie proves accretive to consolidated EBITDA, will also be watched closely. Additional metrics to track include paying-user counts, average revenue per paying user, advertising trends, the impact of pricing changes on XTRA and Unlimited tiers, and developments in the structured share-repurchase program.
AI Tools in My Research Process
When evaluating names like GRND, I often turn to Tickeron’s AI Screener to quickly surface comparable setups and monitor how peers are performing on technical and fundamental filters. It helps me cross-check momentum and valuation signals without spending hours on manual screens.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
GRND's RSI Oscillator ascending out of oversold territory
The RSI Oscillator for GRND moved out of oversold territory on November 03, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 12 similar instances when the indicator left oversold territory. In 10 of the 12 cases the stock moved higher. This puts the odds of a move higher at 83%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 32 of 50 cases where GRND's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 64%.
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on GRND as a result. In 61 of 101 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 60%.
The Moving Average Convergence Divergence (MACD) for GRND just turned positive on November 04, 2026. Looking at past instances where GRND's MACD turned positive, the stock continued to rise in 37 of 53 cases over the following month. The odds of a continued upward trend are 70%.
Following a +9.71% 3-day Advance, the price is estimated to grow further. Considering data from situations where GRND advanced for three days, in 178 of 253 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
GRND may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
GRND moved below its 50-day moving average on September 30, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GRND declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
The Aroon Indicator for GRND entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: GRND's P/B Ratio (-207.465) is slightly lower than the industry average of (-2.611). P/E Ratio (29.809) is within average values for comparable stocks, (15.348). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.067) among similar stocks. P/S Ratio (5.663) is also within normal values, averaging (70.854).
The Tickeron SMR rating for this company is 13 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 44 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 70 (best 1 - 100 worst), indicating slightly worse than average price growth. GRND’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 90 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GRND’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry PackagedSoftware
Advertisement